ERBB2 and breast carcinoma: Though prominent yet variable Gal-9 expression was observed in both TME epithelial and stromal cells within cytosolic or nuclear compartments, Gal-9 stromal staining was preferentially observed in TN and human epidermal growth factor receptor 2 (HER2) breast cancer subtypes [155].